Es gab 50 kürzliche Insider-Transaktionen für Traws Pharma, Inc. (TRAW), darunter 39 Käufe und 4 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $8.06M und die gesamten Insider-Verkäufe auf $963.48.
Bedeutende Insider mit kürzlicher Aktivität umfassen Stover Jack E, Cautreels Werner, Leaman John Harold. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — TRAW
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-08 |
Stover Jack E |
Director |
RSU-Zuteilung |
33,435 |
$1.60 |
$53.5K |
33,435 |
| 2026-03-08 |
Cautreels Werner |
Director |
RSU-Zuteilung |
31,258 |
$1.60 |
$50.01K |
31,258 |
| 2026-03-08 |
Leaman John Harold |
Director |
RSU-Zuteilung |
33,435 |
$1.60 |
$53.5K |
33,435 |
| 2026-03-08 |
Dukes Iain D. |
Chief Executive Officer |
RSU-Zuteilung |
231,336 |
$1.60 |
$370.14K |
231,336 |
| 2026-03-08 |
Shoemaker Mary Teresa |
Director |
RSU-Zuteilung |
33,435 |
$1.60 |
$53.5K |
33,435 |
| 2026-03-08 |
Clarke Trafford |
Director |
RSU-Zuteilung |
33,435 |
$1.60 |
$53.5K |
33,435 |
| 2026-03-08 |
Savchuk Nikolay |
Chief Operating Officer |
RSU-Zuteilung |
96,899 |
$1.60 |
$155.04K |
96,899 |
| 2026-03-08 |
Pauza Charles David |
Chief Science Officer Virology |
RSU-Zuteilung |
118,367 |
$1.60 |
$189.39K |
118,367 |
| 2026-03-08 |
Redfield Robert |
Chief Medical Officer |
RSU-Zuteilung |
108,854 |
$1.60 |
$174.17K |
108,854 |
| 2025-12-12 |
Stover Jack E |
Director |
RSU-Zuteilung |
6,157 |
- |
- |
6,165 |
| 2025-12-12 |
Cautreels Werner |
Director |
RSU-Zuteilung |
19,496 |
$2.33 |
$45.43K |
19,496 |
| 2025-12-12 |
Leaman John Harold |
Director |
RSU-Zuteilung |
4,058 |
- |
- |
4,058 |
| 2025-12-12 |
Dukes Iain D. |
Chief Executive Officer |
RSU-Zuteilung |
147,771 |
$2.33 |
$344.31K |
147,771 |
| 2025-12-12 |
Shoemaker Mary Teresa |
Director |
RSU-Zuteilung |
6,157 |
- |
- |
6,292 |
| 2025-12-12 |
Clarke Trafford |
Director |
RSU-Zuteilung |
6,157 |
- |
- |
6,157 |
| 2025-12-12 |
Savchuk Nikolay |
Chief Operating Officer |
RSU-Zuteilung |
65,676 |
$2.33 |
$153.03K |
65,676 |
| 2025-12-12 |
Pauza Charles David |
Chief Science Officer Virology |
RSU-Zuteilung |
73,886 |
$2.33 |
$172.15K |
73,886 |
| 2025-12-12 |
Redfield Robert |
Chief Medical Officer |
RSU-Zuteilung |
65,676 |
$2.33 |
$153.03K |
65,676 |
| 2025-11-21 |
Leaman John Harold |
Director |
RSU-Zuteilung |
12,770 |
$2.31 |
$29.5K |
12,770 |
| 2025-10-12 |
Stover Jack E |
Director |
RSU-Zuteilung |
11,530 |
$3.01 |
$34.71K |
11,530 |
| 2025-10-12 |
Cautreels Werner |
Director |
RSU-Zuteilung |
11,530 |
$3.01 |
$34.71K |
11,530 |
| 2025-10-12 |
Dukes Iain D. |
Chief Executive Officer |
RSU-Zuteilung |
64,839 |
$3.01 |
$195.17K |
64,839 |
| 2025-10-12 |
Shoemaker Mary Teresa |
Director |
RSU-Zuteilung |
11,530 |
$3.01 |
$34.71K |
11,530 |
| 2025-10-12 |
Clarke Trafford |
Director |
RSU-Zuteilung |
11,530 |
$3.01 |
$34.71K |
11,530 |
| 2025-10-12 |
Savchuk Nikolay |
Chief Operating Officer |
RSU-Zuteilung |
22,435 |
$3.01 |
$67.53K |
22,435 |
| 2025-10-12 |
Pauza Charles David |
Chief Science Officer Virology |
RSU-Zuteilung |
32,406 |
$3.01 |
$97.54K |
32,406 |
| 2025-10-12 |
Redfield Robert |
Chief Medical Officer |
RSU-Zuteilung |
32,406 |
$3.01 |
$97.54K |
32,406 |
| 2025-10-01 |
Leaman John Harold |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-10-01 |
Leaman John Harold |
Director |
RSU-Zuteilung |
15,609 |
$1.89 |
$29.5K |
15,609 |
| 2025-06-19 |
Stover Jack E |
Director |
RSU-Zuteilung |
23,000 |
$1.65 |
$37.95K |
23,000 |
| 2025-06-19 |
Cautreels Werner |
Director |
RSU-Zuteilung |
23,000 |
$1.65 |
$37.95K |
23,000 |
| 2025-06-19 |
Shoemaker Mary Teresa |
Director |
RSU-Zuteilung |
23,000 |
$1.65 |
$37.95K |
23,000 |
| 2025-06-19 |
Clarke Trafford |
Director |
RSU-Zuteilung |
23,000 |
$1.65 |
$37.95K |
23,000 |
| 2025-04-02 |
Tpav, Llc |
10 Percent Owner |
Sonstige (Verkauf) |
2,264 |
- |
- |
- |
| 2025-02-18 |
Cautreels Werner |
Chief Executive Officer |
Optionsausübung (Verkauf) |
96,348 |
$0.01 |
$963.48 |
- |
| 2025-02-05 |
Brennan Nora |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-02-05 |
Guerin Mark Patrick |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-12-29 |
Orbimed Advisors Llc |
10 Percent Owner |
Informierter Kauf |
96,348 |
$13.42 |
$1.29M |
96,348 |
| 2024-12-29 |
Cautreels Werner |
Chief Executive Officer |
Informierter Kauf |
96,348 |
$13.42 |
$1.29M |
96,348 |
| 2024-12-29 |
Tpav, Llc |
10 Percent Owner |
Informierter Kauf |
96,348 |
$13.42 |
$1.29M |
96,348 |
| 2024-12-29 |
Savchuk Nikolay |
10 Percent Owner, Officer: Chief Operating Officer |
Informierter Kauf |
96,348 |
$13.42 |
$1.29M |
96,348 |
| 2024-09-16 |
Greenwood Luba |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-09-16 |
Greenwood Luba |
Director |
RSU-Zuteilung |
164,000 |
$0.34 |
$55.76K |
164,000 |
| 2024-09-16 |
Orbimed Advisors Llc |
10 Percent Owner |
Unbekannt |
676,469 |
- |
- |
- |
| 2024-06-18 |
Guerin Mark Patrick |
CFO |
Optionsausübung (Verkauf) |
5,500 |
- |
- |
5,500 |
| 2024-06-10 |
Guerin Mark Patrick |
CFO |
Optionsausübung |
5,500 |
- |
- |
41,476 |
| 2024-04-03 |
Viriom, Inc. |
10 Percent Owner |
Veräußerung |
48,011,144 |
- |
- |
- |
| 2024-04-01 |
Orbimed Advisors Llc |
10 Percent Owner |
Unbekannt |
25,843,663 |
- |
- |
- |
| 2024-04-01 |
Cautreels Werner |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-04-01 |
Cautreels Werner |
Chief Executive Officer |
RSU-Zuteilung |
200,000 |
$0.01 |
$2K |
200,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
